Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives

J Crohns Colitis. 2018 Apr 27;12(5):610-620. doi: 10.1093/ecco-jcc/jjx181.

Abstract

Thiopurines, available as azathioprine, mercaptopurine, and thioguanine, are immunomodulating agents primarily used to maintain corticosteroid-free remission in patients with inflammatory bowel disease. To provide a state-of-the-art overview of thiopurine treatment in inflammatory bowel disease, this clinical review critically summarises the available literature, as assessed by several experts in the field of thiopurine treatment and research in inflammatory bowel disease.

Publication types

  • Review

MeSH terms

  • Azathioprine / pharmacology
  • Azathioprine / therapeutic use*
  • Drug Therapy, Combination
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use*
  • Inflammatory Bowel Diseases / drug therapy*
  • Infliximab / therapeutic use
  • Mercaptopurine / pharmacology
  • Mercaptopurine / therapeutic use*
  • Neoplasms / epidemiology*
  • Risk Factors
  • Thioguanine / pharmacology
  • Thioguanine / therapeutic use*

Substances

  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Infliximab
  • Mercaptopurine
  • Thioguanine
  • Azathioprine